Aicaigou LogoB2B Wiki

Chronic Prostatitis

Updated: 2026-09-11

Overview

Chronic Prostatitis refers to persistent prostate inflammation lasting over three months, representing 90% of prostatitis cases. The NIH classifies it into Category II (bacterial) and Category III (non-bacterial, further divided into inflammatory/IIIa and non-inflammatory/IIIb subtypes). Unlike acute prostatitis, chronic forms often lack fever but present with recurring pelvic pain, urinary symptoms (dysuria, nocturia), and psychological distress. Prevalence peaks among men aged 36-50, significantly impacting quality of life through sleep disruption and sexual dysfunction.

Key Features

The hallmark symptom is chronic pelvic pain localized to the perineum, suprapubic area, or genitals, often described as dull or pressure-like. Up to 50% of patients experience lower urinary tract symptoms (LUTS) resembling BPH, including weak stream and post-void dribbling. Unique to Category III is the absence of proven infection despite inflammatory markers in expressed prostatic secretions (EPS). Many cases exhibit myofascial trigger points in pelvic floor muscles, suggesting a neuromuscular component. Symptom fluctuation with stress or activity is characteristic.

Application Areas

Urologists utilize the NIH Chronic Prostatitis Symptom Index (CPSI) for standardized assessment, scoring pain (0-21), urinary symptoms (0-10), and quality of life (0-12). Multiparametric MRI (PI-RADS) helps exclude malignancy in refractory cases. Treatment protocols vary: Category II requires 4-12 weeks of fluoroquinolones, while Category III may combine alpha-blockers (tamsulosin), anti-inflammatories (NSAIDs), and pelvic floor physiotherapy. Emerging therapies include pulsed electromagnetic fields and neuromodulation devices for pain control.

Precautions

Misdiagnosis is common due to symptom overlap with interstitial cystitis or pudendal neuralgia. Prostate massage for EPS collection should avoid acute infection phases. Routine antibiotic use without culture confirmation contributes to antimicrobial resistance. Patients should be counseled about stress management, as anxiety exacerbates symptoms. Thermal therapies (sitz baths) and activity modification (reducing cycling pressure) are non-pharmacological precautions. Regular PSA monitoring is advised for patients over 50 due to cancer risk.

B2B Procurement Guide

Hospitals should source FDA-approved bacterial localization kits (e.g., Meares-Stamey test materials) and validated pain scales (NIH-CPSI forms). For clinics, portable biofeedback devices (EMG pelvic floor monitors) aid in physical therapy programs. Pharmaceutical procurement focuses on extended-release formulations of alpha-blockers (silodosin) and specialty compounded medications like intraprostatic botulinum toxin injections. Bulk purchasing agreements for antimicrobial susceptibility test panels can reduce lab costs by 15-20%.

Related Manufacturers